Liver Cancer
FDA Approves Opdivo With Yervoy for Unresectable or Metastatic Hepatocellular Carcinoma
The FDA has approved nivolumab (Opdivo, Bristol Myers Squibb) with ipilimumab (Yervoy, Bristol Myers Squibb) for ...
APRIL 23, 2025
Expert Picks From EASL 2024
Ashwani K. Singal, MD, MS, highlights four abstracts from EASL Congress 2024.
OCTOBER 30, 2024
Noninvasive Tools Can Predict Liver-Related Events
A combination of a liver stiffness measurement and clinical parameters may allow prediction of liver-related ...
AUGUST 26, 2024
Expert Picks From AASLD 2023
In this installment of Expert Picks, Ashwani Singal, MD, MS, discusses five of his favorite abstracts from The ...
FEBRUARY 14, 2024
Improved Biomarkers Can Aid HCC Diagnosis, Predict Disease Course
Researchers in the Netherlands and Latin America have identified a new score using existing serum biomarkers to ...
DECEMBER 23, 2023
New Research, Guidelines and More That Changed Gastroenterology in 2023
The gastroenterology field was full of new developments in 2023.
DECEMBER 21, 2023
Albumin-Bilirubin Grade Proposed as Prognostic Tool in Hepatocellular Carcinoma
Results of a retrospective study suggest that the albumin-bilirubin grade might be more useful in classifying ...
OCTOBER 30, 2023
Novel First-Line Therapy’s OS Benefit for Liver Cancer Persists
Long-term overall survival in hepatocellular carcinoma with tremelimumab plus durvalumab treatment is durable, ...
OCTOBER 27, 2023
Tislelizumab Vies for First-Line Designation in Treatment of Advanced HCC
The checkpoint inhibitor tislelizumab might reasonably be considered a better choice for hepatocellular carcinoma ...
OCTOBER 20, 2023
Better Outcomes, No Reduced Safety When Sorafenib Is Preceded by Stereotactic Body RT for HCC
Administering stereotactic body radiation therapy before sorafenib significantly improves overall and ...
JUNE 6, 2023
DDW Liver Disease Programming Preview With Grace Su, MD
Grace Su, MD, previews some highlights of AASLD’s DDW 2023 programming.
MAY 1, 2023
Multiple-Target Blood Test Detects Liver Cancer After Cirrhosis
For surveillance of patients with cirrhosis, a novel blood test found more hepatocellular carcinoma at an early ...
MAY 31, 2022
